After 20 years on the market, AbbVie’s dry-eye drug Restasis to be available as generic
By
Alicia Lasek
Feb 03, 2022
Dry eyes affect nearly 19% percent of adults aged 75 years and older, according to data from a national survey.
Memory loss may linger eight months after mild coronavirus infection, study finds
By
Alicia Lasek
Aug 17, 2021
The results suggest that COVID-19 may not really be a mild disease, no matter its course, investigators say. They also raise the question of whether current home-treatment strategies are optimal for long-term...
Cardiac rehab should start with depression screening, researcher says
By
Alicia Lasek
Oct 10, 2019
With nearly 20% of cardiac rehabilitation patients being depressed and anxious, outcomes may hinge on how clinicians handle mental health care.
Silos, shortages hamper transitions to long-term care, physician experts report
By
Alicia Lasek
Apr 21, 2023
Most care transitions to LTC are effective. But fragmentation of care delivery, communication issues and worker shortages are the top barriers to success, say the authors of a new survey-based report from...
Metformin may slow cognitive decline in people with diabetes
By
Alicia Lasek
Sep 25, 2020
Researchers have found new potential for a safe and widely used medication. The discovery could be “life-changing” for patients at risk of dementia, they say.
Pandemic safety measures raised seniors’ risk for depression, anxiety, analysts say
By
Alicia Lasek
Apr 05, 2022
Older adults who stayed at home and practiced social distancing during the pandemic were more likely to experience mental health problems, including twice the risk of depressive symptoms, a new study finds.
GAO: Nursing homes unlikely to use point-of-care COVID tests in states that question accuracy
By
Alicia Lasek
Jan 29, 2021
A disconnect between federal and state or local policies has a direct effect on POC antigen test use in these settings, according to a comprehensive report released Thursday by the U.S. Government Accountability...
What providers can learn from the first US coronavirus outbreak
By
Alicia Lasek
Mar 19, 2020
Long-term care staff inadvertently spread coronavirus between facilities in the early days of the first U.S. outbreak in Washington.
Promising antidepressant fails in late-stage trial
By
Alicia Lasek
Dec 05, 2019
Fast-tracked antidepressant Sage-217 failed to outperform a placebo in a stage 3 trial, according to its developer.
FDA halts use of REGEN-COV, Eli Lilly monoclonal antibodies
By
Alicia Lasek
Jan 26, 2022
The Food and Drug Administration has revoked its emergency use authorizations for two monoclonal antibody cocktails that have served as COVID-19 treatment mainstays in long-term care facilities.